Peptide Payment Processing: Why It's So Hard and What Actually Works

If you run a peptide company, you already know this story. You apply for a merchant account, everything seems fine, and then the bank's risk team gets involved. Suddenly your application is declined, your existing account gets frozen, or you're told the category is outside their risk appetite. No real explanation, no path forward. Just a no.

This happens constantly in the peptide space. And frankly, it's not because processors are being unreasonable across the board. The peptide industry has a real compliance problem. Some companies are selling compounds that are not legal for human use, shipping internationally without proper documentation, or operating without any meaningful oversight of their supply chain or prescribing practices. That bad behavior creates risk exposure for banks, and banks respond by shutting the whole category out.

The problem is that it punishes the legitimate operators alongside the bad ones. If your company has a real compliance program, works with licensed prescribers, and is doing this the right way, you still get lumped in with everyone else when a processor's underwriting team sees "peptides" on an application.

So what do you actually do about it?

Why Standard Processors Won't Touch Peptides

Most payment processors operate with very broad restriction lists. Terms like "pharmaceuticals," "nutraceuticals," and "research chemicals" often appear on those lists, and peptides get swept in under one or more of those categories depending on how the underwriter reads your business description.

There are a few specific things that make underwriters nervous about peptide companies:

• The regulatory status of peptides varies by compound and by jurisdiction. Some are FDA-approved drugs, some are research-use-only compounds, and some exist in a gray area that changes depending on how they're marketed and sold.
• Chargeback rates in the peptide industry have historically been high, driven partly by consumers who buy from questionable sources and dispute charges when a product doesn't work or never arrives.
• The prescribing and dispensing practices of some peptide companies have attracted regulatory attention, creating legal and reputational risk for any processor associated with them.
• International shipping of peptide compounds creates additional customs and legal complexity that most processors are not equipped to evaluate.

None of these concerns go away on their own. But they can be addressed if you can demonstrate that your operation is built differently.

What LegitScript Is and Why It Changes the Conversation

LegitScript is an independent certification and monitoring company that verifies whether healthcare-related businesses are operating in compliance with applicable laws and regulations. They are best known in the pharmacy and telehealth space, but they also certify peptide and nutraceutical companies that meet their compliance standards.

For peptide companies, LegitScript certification is not easy to get. They look at your entire operation: what compounds you're selling, how they're being prescribed or recommended, your dispensing practices, your supply chain, your marketing claims, and whether your business model is structured in a way that is defensible under current law. The process takes time and requires real documentation.

But here's why it matters for payment processing: LegitScript operates a merchant monitoring program that major payment networks and processors actually use. When a processor sees that your company is LegitScript certified, it changes the risk profile of your application entirely. It signals that a credible third party has already reviewed your compliance posture and found it acceptable. That's a very different conversation than walking in cold with a peptide company and hoping for the best.

Visa and Mastercard both require LegitScript certification for certain healthcare and pharmaceutical merchant categories. Some of the larger processors will not even consider a peptide company without it. Getting certified is not a guarantee you'll get approved, but operating without it in this category makes an already hard situation significantly harder.

The LegitScript Certification Process

The certification process typically involves the following:

• An initial application describing your business, the products you sell, your prescribing model, and your regulatory standing.
• Documentation of your supply chain, including where compounds are sourced, how they're tested, and how they're dispensed.
• Review of your marketing materials to ensure claims are accurate and not misleading under FDA guidelines.
• Verification that prescriptions are being issued by licensed practitioners through a legitimate clinical process, not rubber-stamped or bypassed entirely.
• Ongoing monitoring after certification to ensure continued compliance.

LegitScript charges fees for certification and ongoing monitoring. The cost is real, but so is the upside. If payment processing is a bottleneck for your business right now, the ROI on getting certified is almost always worth it.

We Can Help with LegitScript Consulting

Getting through the LegitScript process on your own is doable, but it takes time and the application is detailed. We work with peptide companies through the certification process, helping them understand what documentation is needed, how to structure their compliance documentation, and what LegitScript reviewers are actually looking for.

This matters because a lot of companies go into the LegitScript process without a clear picture of what's expected and end up going back and forth for months. Having someone in your corner who has been through this with other companies in your category can shorten that timeline significantly.

What Peptide Payment Processing Actually Looks Like

Once a peptide company has LegitScript certification or is actively working through the process, we can have a real conversation about merchant services. Here's what that typically involves:

Dedicated high-risk underwriting. Your account goes through underwriters who actually understand the peptide and nutraceutical space. They know what LegitScript certification means, they know how to read your business model, and they're not declining you on a blanket category restriction.

Realistic reserve requirements. High-risk accounts often carry a rolling reserve, where a percentage of processing volume is held for a period to cover potential chargebacks. We work to structure reserves that are reasonable relative to your actual chargeback history rather than applying maximum reserves across the board because your category is flagged.

Chargeback monitoring and dispute support. Peptide companies need to take chargebacks seriously. A rate above 1% will get your account terminated at most processors. We provide tools and support to help manage disputes before they become a volume problem.

Transparent pricing. High-risk processing costs more than standard processing. That's just the reality. But there's a wide range between reasonable and predatory, and a lot of peptide companies end up on the wrong side of that line because they were so relieved to get approved that they didn't negotiate. We try to be straightforward about what you're paying and why.

If You're Operating a Legitimate Peptide Business, There Is a Path

The peptide payment processing problem is real, but it's not unsolvable. The companies that are getting declined over and over again are usually either missing LegitScript certification, have a compliance model that won't hold up to scrutiny, or are working with processors who simply don't have the infrastructure to underwrite this category properly.

If your business is built on legitimate prescribing practices, you're working with licensed practitioners, and your supply chain is clean, we can work with you. The first step is usually a conversation about where you are in the LegitScript process and what your current payment situation looks like. From there, we figure out the fastest path to a stable, long-term processing solution.

It's not instant. But it's possible.